微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | -3.2% | -9.97% | -74.86% | 129/159 | 4.19% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | -1.83% | 6.63% | -473.47% | 123/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 0.49% | 104.17% | 101.9% | 105/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | -25.81% | -52.09% | -786.94% | 137/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | -2.91% | -827.5% | -48.47% | 120/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | -1.96% | 34.67% | -916.67% | 123/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.24% | 106.94% | 101.41% | 104/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | -16.97% | 67.15% | -4342.5% | 130/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 0.4% | 102.95% | 113.33% | 110/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | -3% | 46.81% | 13.29% | 128/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | -3.46% | -2406.67% | 93.3% | 133/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -51.66% | -18550% | -280.69% | 144/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | -13.57% | -722.48% | -140.6% | 135/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | -5.64% | -380.6% | -3860% | 126/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 0.15% | -84.38% | -46.43% | 114/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 0.28% | -96.32% | -87.16% | 110/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.18% | -68.95% | 8.46% | 95/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 2.01% | -61.49% | 109.38% | 85/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 0.96% | -59.66% | -87.37% | 93/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 7.6% | -14.99% | 8.26% | 59/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 7.02% | -3.31% | 34.48% | 61/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 5.22% | 11.54% | 119.33% | 53/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.38% | 33.71% | -73.38% | 56/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 8.94% | 8.1% | 23.14% | 64/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.26% | -2.68% | 55.13% | 55/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 4.68% | 3.08% | 162.92% | 58/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 1.78% | -20.18% | -78.48% | 54/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 8.27% | 49.01% | 10.86% | 68/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 7.46% | 12.01% | 64.32% | 49/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.54% | 5.09% | 103.59% | 54/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 2.23% | 17.37% | -59.82% | 52/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 5.55% | -33.05% | -16.67% | 81/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 6.66% | 14.83% | 54.17% | 49/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.32% | 18.68% | 127.37% | 49/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 1.9% | -0.52% | -77.08% | 57/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 8.29% | -10.86% | 42.93% | 60/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 5.8% | -10.36% | 59.34% | 59/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 3.64% | -14.75% | 90.58% | 66/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 1.91% | 1.06% | -79.46% | 45/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 9.3% | -8.46% | 43.74% | 61/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 6.47% | 17% | 51.52% | 42/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 4.27% | 11.2% | 125.93% | 44/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 1.89% | 23.53% | -81.4% | 41/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |